SG78336A1 - Pyrazolopyrimidines and pyrazolotriazines - Google Patents

Pyrazolopyrimidines and pyrazolotriazines

Info

Publication number: SG78336A1
Authority: SG; Singapore
Prior art keywords: pyrazolotriazines; pyrazolopyrimidines
Prior art date: 1998-03-11

Application number

SG1999001080A

Other languages

English (en)

Inventor

Michael Bos

Claus Riemer

Heinz Stadler

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-11

Filing date

1999-03-09

Publication date

2001-02-20

1999-03-09 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2001-02-20 Publication of SG78336A1 publication Critical patent/SG78336A1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Veterinary Medicine (AREA)
Psychiatry (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

SG1999001080A 1998-03-11 1999-03-09 Pyrazolopyrimidines and pyrazolotriazines SG78336A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP98104346		1998-03-11

Publications (1)

Publication Number	Publication Date
SG78336A1 true SG78336A1 (en)	2001-02-20

Family

ID=8231568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG1999001080A SG78336A1 (en)	1998-03-11	1999-03-09	Pyrazolopyrimidines and pyrazolotriazines

Country Status (33)

Country	Link
US (1)	US6194410B1 (fr)
EP (1)	EP0941994B1 (fr)
JP (1)	JP3231288B2 (fr)
KR (1)	KR100313181B1 (fr)
CN (1)	CN1118468C (fr)
AR (1)	AR016453A1 (fr)
AT (1)	ATE240332T1 (fr)
AU (1)	AU752408B2 (fr)
BR (1)	BR9901095A (fr)
CA (1)	CA2265095C (fr)
CZ (1)	CZ291514B6 (fr)
DE (1)	DE69907784T2 (fr)
DK (1)	DK0941994T3 (fr)
ES (1)	ES2198095T3 (fr)
HR (1)	HRP990077B1 (fr)
HU (1)	HUP9900589A1 (fr)
ID (1)	ID23575A (fr)
IL (1)	IL128869A (fr)
MA (1)	MA26612A1 (fr)
MY (1)	MY119536A (fr)
NO (1)	NO312297B1 (fr)
NZ (1)	NZ334526A (fr)
PE (1)	PE20000337A1 (fr)
PL (1)	PL331875A1 (fr)
PT (1)	PT941994E (fr)
RU (1)	RU2218340C2 (fr)
SG (1)	SG78336A1 (fr)
SI (1)	SI0941994T1 (fr)
TR (1)	TR199900531A2 (fr)
TW (1)	TW585865B (fr)
UY (1)	UY25419A1 (fr)
YU (1)	YU12099A (fr)
ZA (1)	ZA991946B (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000059907A2 (fr)	1999-04-06	2000-10-12	Du Pont Pharmaceuticals Company	Pyrazolotriazines antagonistes de corticoliberine (crf)
DE19956791A1 (de) *	1999-11-25	2001-05-31	Merck Patent Gmbh	Neue Sulfonyloxazolamine
PE20020394A1 (es)	2000-08-18	2002-06-21	Agouron Pharma	Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
CA2440553C (fr) *	2001-03-13	2010-06-08	Paul J. Gilligan	4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo-[1,5-a]-1,3,5-triazine, ses enantiomeres et sels pharmaceutiquement acceptables en tant que ligands du recepteur de la corticoliberine
EP1401813B1 (fr)	2001-06-07	2007-02-07	F. Hoffman-la Roche AG	Nouveaux derives de l'indole a affinite pour le recepteur 5-ht6
MXPA03011638A (es)	2001-06-15	2004-04-02	Hoffmann La Roche	Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6.
EP1414442A1 (fr) *	2001-08-07	2004-05-06	Smithkline Beecham Plc	3-arylsulfonyl-7-piperazinyl- indols, -benzofurans et benzothiophenes a affinite avec les recepteurs 5-ht6 pour le traitement de troubles du snc
JP4335684B2 (ja) *	2001-12-20	2009-09-30	ワイス	５−ヒドロキシトリプタミン−６リガンドとしてのインドリルアルキルアミン誘導体
US6642381B2 (en) *	2001-12-27	2003-11-04	Hoffman-La Roche Inc.	Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
GB0202679D0 (en) *	2002-02-05	2002-03-20	Glaxo Group Ltd	Novel compounds
UA78999C2 (en) *	2002-06-04	2007-05-10	Wyeth Corp	1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
US6875771B2 (en)	2002-07-26	2005-04-05	Bristol-Myers Squibb Company	Pyridopyrimidine derivatives as 5-HT6 antagonists
AR041137A1 (es) *	2002-09-04	2005-05-04	Pharmacopeia Drug Discovery	Pirazolopirimidinas como inhibidores de quinasa dependientes de ciclinas
US7196078B2 (en) *	2002-09-04	2007-03-27	Schering Corpoartion	Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
US7329658B2 (en) *	2003-02-06	2008-02-12	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
EP1592690A1 (fr) *	2003-02-14	2005-11-09	Wyeth	Derives de heterocyclyl-3-sulfonylazaindole ou -azaindazole utilises comme ligands de la 5-hydroxytryptamine-6
CA2516824A1 (fr)	2003-02-28	2004-09-10	Teijin Pharma Limited	Derives de pyrazolo[1,5-a]pyrimidine
GB0305559D0 (en) *	2003-03-11	2003-04-16	Teijin Ltd	Compounds
US7585881B2 (en) *	2004-02-18	2009-09-08	Astrazeneca Ab	Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
WO2005112936A1 (fr) *	2004-05-14	2005-12-01	The Regents Of The University Of Michigan	Compositions et methodes associees aux inhibiteurs de la proteine kinase
CN101094853B (zh) *	2004-11-04	2011-07-13	沃泰克斯药物股份有限公司	可用作蛋白激酶抑制剂的吡唑并[1,5-a]嘧啶
RU2390523C2 (ru) *	2005-10-21	2010-05-27	Мицубиси Танабе Фарма Корпорейшн	ПРОИЗВОДНОЕ ПИРАЗОЛ[1,5-a]ПИРИМИДИНА
RU2330854C2 (ru) *	2006-03-15	2008-08-10	Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию" (ГОУВПО "ПГФА Росздрава")	Способ получения конденсированных гем-диметилзамещенных амино-1,3,5-триазинов
EA017968B1 (ru) *	2008-01-24	2013-04-30	Андрей Александрович ИВАЩЕНКО	ЗАМЕЩЕННЫЕ 2-АМИНО-3-СУЛЬФОНИЛПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ-АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-НТРЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
EP2248814A4 (fr)	2008-01-24	2011-01-12	Alla Chem Llc	Cyclo-alcanoýe et d¨pyrazoloý1,5-a¨pyrimidines substituées fonctionnant comme des antagonistes des récepteurs 5-ht6 de sérotonine, procédés de fabrication et d'utilisation
RU2369600C1 (ru) *	2008-01-24	2009-10-10	Андрей Александрович Иващенко	ЗАМЕЩЕННЫЕ 4-СУЛЬФОНИЛ-ПИРАЗОЛЫ И 3-СУЛЬФОНИЛ-ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ5-HT6 РЕЦЕПТОРОВ, АКТИВНЫЙ КОМПОНЕНТ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ЛЕКАРСТВЕННОЕ СРЕДСТВО И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
EA017805B1 (ru) *	2008-01-24	2013-03-29	Андрей Александрович ИВАЩЕНКО	2-АЛКИЛАМИНО-3-АРИЛСУЛЬФОНИЛЦИКЛОАЛКАНО[e ИЛИ d]ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-НТРЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
RU2384581C2 (ru)	2008-05-07	2010-03-20	Андрей Александрович Иващенко	ЗАМЕЩЕННЫЕ 2-АМИНО-3-СУЛЬФОНИЛ-ТЕТРАГИДРО-ПИРАЗОЛО[1,5-a]ПИРИДО-ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6 РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
EA017630B1 (ru) *	2008-10-06	2013-01-30	Андрей Александрович ИВАЩЕНКО	ЗАМЕЩЕННЫЕ 3-АРИЛСУЛЬФОНИЛПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ, АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT-РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
WO2010060952A1 (fr) *	2008-11-27	2010-06-03	Boehringer Ingelheim International Gmbh	Dérivés de 6,7,8,9-tétrahydro-5h-1,4,7,10a-tétraaza-cyclohept[f]indène, compositions pharmaceutiques contenant ces composés, leur utilisation et procédés pour préparer ceux-ci
GB0908394D0 (en)	2009-05-15	2009-06-24	Univ Leuven Kath	Novel viral replication inhibitors
GB0913636D0 (en)	2009-08-05	2009-09-16	Univ Leuven Kath	Novel viral replication inhibitors
AU2011331301A1 (en)	2010-11-15	2013-05-23	Katholieke Universiteit Leuven	Antiviral condensed heterocyclic compounds
RU2443697C1 (ru)	2010-12-21	2012-02-27	Александр Васильевич Иващенко	Замещенные метил-амины, антагонисты серотониновых 5-ht6 рецепторов, способы получения и применения
PT2760453T (pt)	2011-09-30	2016-08-02	Ipsen Pharma Sas	Inibidores macrocíclicos da cinase lrrk2
AU2013230128B2 (en) *	2012-03-09	2017-08-17	Lexicon Pharmaceuticals, Inc.	Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
TW201542550A (zh) *	2013-09-06	2015-11-16	Lexicon Pharmaceuticals Inc	吡唑并［１，５－ａ］嘧啶基化合物、包含彼之組合物以及使用彼之方法
TW201620911A (zh) *	2014-03-17	2016-06-16	雷西肯製藥股份有限公司	銜接子關聯激酶１之抑制劑、包含其之組成物、及其使用方法
EA032838B1 (ru)	2014-09-17	2019-07-31	Онкодизайн С.А.	Макроциклические ингибиторы lrrk2-киназы
US11186576B2 (en)	2015-03-09	2021-11-30	Aurigene Discovery Technologies Limited	Pyrazolo[1,5-A][1,3,5]triazine and pyrazolo[1,5-A]pyrimidine derivatives as CDK inhibitors
WO2017052394A1 (fr) *	2015-09-23	2017-03-30	Uniwersytet Jagielloński	Composés d'imidazopyridine et leur utilisation comme ligands du récepteur 5-ht6
HK1256751A1 (zh)	2015-11-02	2019-10-04	Janssen Pharmaceutica Nv	[1，2，4]三唑并[1，5-a]嘧啶-7-基化合物
CN109890824B (zh)	2016-11-02	2022-05-24	詹森药业有限公司	作为pde2抑制剂的[1,2,4]三唑并[1,5-a]嘧啶化合物
EP3535269B1 (fr)	2016-11-02	2020-12-09	Janssen Pharmaceutica NV	Composés de [1,2,4]triazolo[1,5-a]pyrimidine comme inhibiteurs de pde2
EP3535267B1 (fr)	2016-11-02	2020-12-30	Janssen Pharmaceutica NV	Dérivés de [1,2,4]triazolo[1,5-a]pyrimidine comme inhibiteurs de pde2
SG11202112229UA (en)	2019-05-05	2021-12-30	Qilu Regor Therapeutics Inc	Cdk inhibitors
CN112142744A (zh) *	2019-06-28	2020-12-29	上海瑛派药业有限公司	取代的稠合杂芳双环化合物作为激酶抑制剂及其应用
MX2022008627A (es)	2020-01-13	2022-11-08	Verge Analytics Inc	Pirazolo-pirimidinas sustituidas y usos de las mismas.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3907799A (en) *	1971-08-16	1975-09-23	Icn Pharmaceuticals	Xanthine oxidase inhibitors
US4921527A (en) *	1987-07-31	1990-05-01	E. I. Du Pont De Nemours And Company	Herbicidal sulfonamides
EP0368897A1 (fr)	1987-07-31	1990-05-23	E.I. Du Pont De Nemours And Company	Sulfonamides herbicides
DE3825043A1 (de)	1988-07-20	1990-02-15	Schering Ag	3-methylsulfonyl-pyrazolo(1,5-a)pyrimidin-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider, pflanzenwuchsregulierender und fungizider wirkung
US5571813A (en) *	1993-06-10	1996-11-05	Beiersdorf-Lilly Gmbh	Fused pyrimidine compounds and their use as pharmaceuticals
WO1997011075A1 (fr)	1995-09-22	1997-03-27	Takeda Chemical Industries, Ltd.	Composes de triazole, leur production et utilisation
DZ2376A1 (fr)	1996-12-19	2002-12-28	Smithkline Beecham Plc	Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
JP2001506995A (ja)	1996-12-19	2001-05-29	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	Ｎ−ピペラジン−１−イルフェニル−ベンズアミド誘導体
ATE296811T1 (de)	1997-07-11	2005-06-15	Smithkline Beecham Plc	Sulfonamid-derivate als 5-ht6 receptor antagonisten und verfahren zu ihrer herstellung

1999
- 1999-02-24 US US09/256,927 patent/US6194410B1/en not_active Expired - Fee Related
- 1999-03-03 DK DK99102872T patent/DK0941994T3/da active
- 1999-03-03 EP EP99102872A patent/EP0941994B1/fr not_active Expired - Lifetime
- 1999-03-03 PT PT99102872T patent/PT941994E/pt unknown
- 1999-03-03 AT AT99102872T patent/ATE240332T1/de not_active IP Right Cessation
- 1999-03-03 SI SI9930320T patent/SI0941994T1/xx unknown
- 1999-03-03 ES ES99102872T patent/ES2198095T3/es not_active Expired - Lifetime
- 1999-03-03 DE DE69907784T patent/DE69907784T2/de not_active Expired - Fee Related
- 1999-03-08 YU YU12099A patent/YU12099A/sh unknown
- 1999-03-08 CA CA002265095A patent/CA2265095C/fr not_active Expired - Fee Related
- 1999-03-08 MA MA25485A patent/MA26612A1/fr unknown
- 1999-03-08 PE PE1999000183A patent/PE20000337A1/es not_active Application Discontinuation
- 1999-03-08 IL IL12886999A patent/IL128869A/xx not_active IP Right Cessation
- 1999-03-08 NZ NZ334526A patent/NZ334526A/xx unknown
- 1999-03-09 SG SG1999001080A patent/SG78336A1/en unknown
- 1999-03-09 MY MYPI99000853A patent/MY119536A/en unknown
- 1999-03-09 AR ARP990100990A patent/AR016453A1/es unknown
- 1999-03-09 JP JP06114999A patent/JP3231288B2/ja not_active Expired - Fee Related
- 1999-03-09 UY UY25419A patent/UY25419A1/es unknown
- 1999-03-10 BR BR9901095-0A patent/BR9901095A/pt not_active Application Discontinuation
- 1999-03-10 KR KR1019990007881A patent/KR100313181B1/ko not_active Expired - Fee Related
- 1999-03-10 ID IDP990198D patent/ID23575A/id unknown
- 1999-03-10 RU RU99105137/04A patent/RU2218340C2/ru active
- 1999-03-10 ZA ZA9901946A patent/ZA991946B/xx unknown
- 1999-03-10 HU HU9900589A patent/HUP9900589A1/hu not_active Application Discontinuation
- 1999-03-10 PL PL99331875A patent/PL331875A1/xx unknown
- 1999-03-10 CZ CZ1999825A patent/CZ291514B6/cs not_active IP Right Cessation
- 1999-03-10 NO NO19991150A patent/NO312297B1/no unknown
- 1999-03-10 TW TW088103692A patent/TW585865B/zh not_active IP Right Cessation
- 1999-03-11 AU AU20383/99A patent/AU752408B2/en not_active Ceased
- 1999-03-11 CN CN99105964A patent/CN1118468C/zh not_active Expired - Fee Related
- 1999-03-11 HR HR990077A patent/HRP990077B1/xx not_active IP Right Cessation
- 1999-03-11 TR TR1999/00531A patent/TR199900531A2/xx unknown

Also Published As

Publication number	Publication date
HRP990077B1 (en)	2003-08-31
CA2265095A1 (fr)	1999-09-11
MA26612A1 (fr)	2004-12-20
RU2218340C2 (ru)	2003-12-10
DE69907784D1 (de)	2003-06-18
KR100313181B1 (ko)	2001-11-05
IL128869A (en)	2003-09-17
SI0941994T1 (en)	2003-10-31
MY119536A (en)	2005-06-30
ZA991946B (en)	1999-09-13
NZ334526A (en)	2000-07-28
KR19990077741A (ko)	1999-10-25
TR199900531A3 (tr)	1999-10-21
PL331875A1 (en)	1999-09-13
JP3231288B2 (ja)	2001-11-19
ID23575A (id)	2000-05-04
PE20000337A1 (es)	2000-05-13
CZ82599A3 (cs)	1999-09-15
CZ291514B6 (cs)	2003-03-12
HK1023343A1 (en)	2000-09-08
JP2000186090A (ja)	2000-07-04
CN1236780A (zh)	1999-12-01
PT941994E (pt)	2003-09-30
CA2265095C (fr)	2008-07-22
HRP990077A2 (en)	2000-02-29
NO991150D0 (no)	1999-03-10
AR016453A1 (es)	2001-07-04
EP0941994A1 (fr)	1999-09-15
DK0941994T3 (da)	2003-09-08
EP0941994B1 (fr)	2003-05-14
US6194410B1 (en)	2001-02-27
CN1118468C (zh)	2003-08-20
BR9901095A (pt)	2000-05-02
YU12099A (sh)	2000-10-30
HUP9900589A1 (hu)	2000-03-28
ES2198095T3 (es)	2004-01-16
NO991150L (no)	1999-09-13
UY25419A1 (es)	2001-11-30
TR199900531A2 (xx)	1999-10-21
NO312297B1 (no)	2002-04-22
HU9900589D0 (en)	1999-05-28
AU2038399A (en)	1999-09-23
DE69907784T2 (de)	2004-03-25
ATE240332T1 (de)	2003-05-15
AU752408B2 (en)	2002-09-19
IL128869A0 (en)	2000-01-31
TW585865B (en)	2004-05-01

Publication	Publication Date	Title
HRP990077B1 (en)	2003-08-31	Pyrazolopyrimidines and pyrazolotriazines
HU9903361D0 (en)	1999-12-28	Filter-device with collecting-vessel and with heating-device
DE69834346D1 (en)	2006-06-01	Proteinexpression in baculovirus-vektor expressionsystemen
DE69927412D1 (en)	2006-02-02	Phosphitadditive in polyolefinen
EP1037635A4 (fr)	2002-11-13	Composes et procedes
EP1102535A4 (fr)	2004-09-29	Composes et procedes
HU9900592D0 (en)	1999-04-28	Compound and its use
HUP9700446A3 (en)	1998-04-28	Oilsuspension-concentrate and using thereof
EP1056455A4 (fr)	2000-12-06	Compose d'epimorphine et utilisation de ce dernier
HUP0103473A3 (en)	2003-01-28	Phosphoglycolipid and methods for its use
PL332616A1 (en)	1999-10-25	Hydoxymethylhexanones as odorising and savourising agents
GB9702354D0 (en)	1997-03-26	Compounds and their use
DE69732623D1 (en)	2005-04-07	Analogsignalmultiplexer in strombetriebsart
PL331523A1 (en)	1999-07-19	Azolotrizines and azolopyrimidines
HUP0104723A3 (en)	2004-10-28	New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
GB2321020B (en)	2001-04-25	Footballs
GB9807586D0 (en)	1998-06-10	Enzymes and their use
GB9813778D0 (en)	1998-08-26	Assay methods and means
HUP9900068A3 (en)	2000-06-28	Fuse-switch and/or fuse-disconnector
GB9828004D0 (en)	1999-02-10	Use
GB9807503D0 (en)	1998-06-10	Use
GB9905916D0 (en)	1999-05-05	Emergency kit and associated articles
ZA987425B (en)	1999-02-22	Phenylethanolaminotetralin derivatives and bronchodilators
GB9802016D0 (en)	1998-03-25	Bootsac and coolsac
GB9816014D0 (en)	1998-09-23	Piperidinecarboxamides and their use